Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.
GLOBETECH PUBLISHING

Genetic Clue to Irritable Bowel Syndrome Found

By Labmedica International staff writers
Posted on 03 Apr 2014
Image: Histopathology showing degranulation of eosinophils (pink) with adjacent nerves (brown) in the duodenum of a patient with functional bowel disorder (Photo courtesy of Dr. Marjorie Walker).
Image: Histopathology showing degranulation of eosinophils (pink) with adjacent nerves (brown) in the duodenum of a patient with functional bowel disorder (Photo courtesy of Dr. Marjorie Walker).
Irritable bowel syndrome (IBS) may be caused by genetics, diet, past trauma, anxiety and all are thought to play a role, but now, for the first time, a defined genetic defect that causes a subset of IBS has been reported.

IBS is a common disorder that affects the large intestine and most patients with the disorder commonly experience symptoms of cramping, abdominal pain, bloating gas, diarrhea and constipation and most treatments for IBS target these symptoms. One of the risk factors for IBS is a family history of the syndrome where those who have a first-degree relative, such as a parent or sibling, with IBS are at increased risk of the condition.

An international team of scientists led by those at the Mayo Clinic (Rochester, MN, USA) studied the sodium channel of people with IBS and control subjects. Many of the patients with cardiac arrhythmias which are caused by mutations in the gene sodium channel, voltage-gated, type V, alpha subunit (SCN5A) also have symptoms of IBS. The team investigated whether patients with IBS have SCN5A variants that affect the function of the sodium ion channel protein Nav1.5.

The investigators performed genotype analysis of SCN5A in 584 persons with IBS and 1,380 control subjects. Mutant forms of SCN5A were expressed in Human Embryonic Kidney (HEK)-293 cells, and functions were assessed by voltage clamp analysis. A genome-wide association study (GWAS) was analyzed for an association signal for the SCN5A gene and replicated in 1,745 patients in four independent cohorts of IBS patients and controls.

Missense mutations were found in SCN5A in 13/584 patients (2.2%). Diarrhea-predominant IBS (IBS-D) was the most prevalent form of IBS in the overall study population (25%). However, a significantly greater percentage of individuals with SCN5A mutations had constipation-predominant IBS (IBS-C, 31%) than IBS-D (10%). In the GWAS and four replicated studies, the SCN5A locus was strongly associated with IBS.

The scientists were able to restore function to a patient with constipation predominant IBS with a defective SCN5A gene and resulting abnormally functioning sodium channel. They used a drug called mexiletine, which restored the function of the channel and reversed the patient's symptoms of constipation and abdominal pain. Gianrico Farrugia, MD, a lead study author, said, “This gives us hope that from only treating symptoms of the disease, we can now work to find disease-modifying agents, which is where we really want to be to affect long-term treatment of IBS.” The study was published on March 5, 2014, in the journal Gastroenterology.

Related Links:

Mayo Clinic



Sekisui Diagnostics
EUROIMMUN AG
PURITAN MEDICAL
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: Enzyme-linked immunosorbent kit (ELISA) specific for human copeptin (Photo courtesy of USCN Life Science).

Preeclampsia Biomarker Detected Very Early In Pregnancy

A biomarker has been discovered that could give expecting mothers and their doctors the first simple blood test to reliably predict that a pregnant woman may develop preeclampsia, at least as early as... Read more

Pathology

view channel
Image: Glioblastoma multiforme (GBM) (Photo courtesy of the University of California, San Diego School of Medicine).

Brain Tumor Chemotherapy Biomarkers Identified

Cancer researchers have identified a new biomarker that they believe can predict whether glioblastoma multiformes (GBMs), the most common and aggressive type of malignant brain tumor, will be susceptible... Read more

Lab Tech.

view channel
Image:  The Becton Dickinson fluorescent activated cell sorter FACScan (Photo courtesy of the Albert Einstein College of Medicine).

Noninvasive Method Captures Circulating Tumor Cells

A clinically proven, noninvasive fluorescence virus-guided capture system of human colorectal circulating tumor cells (CTCs) from blood samples for genetic testing has been introduced. This noninvasive... Read more

Industry News

view channel

Beckman Coulter Acquires Siemens Healthcare Diagnostics’ Clinical Microbiology Business

Beckman Coulter (Brea, CA, USA), an indirect wholly-owned subsidiary of Danaher Corp. (Washington DC, MD, USA) has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics (Chicago, IL, USA). The transaction is expected to close in the first quarter of 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.